Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18253104&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Metastasis: a therapeutic target for cancer Steeg PS; Theodorescu DNat Clin Pract Oncol 2008[Apr]; 5 (4): 206-19Metastasis remains the major driver of mortality in patients with cancer. Our growing body of knowledge regarding this process provides the basis for the development of molecularly targeted therapeutics aimed at the tumor cell or its interaction with the host microenvironment. Here we discuss the similarity and differences between primary tumors and metastases, pathways controlling the colonization of a distant organ, and incorporation of antimetastatic therapies into clinical testing.|*Neovascularization, Pathologic[MESH]|Antineoplastic Agents/pharmacology/therapeutic use[MESH]|Capillary Permeability/drug effects[MESH]|Disease Progression[MESH]|ErbB Receptors/drug effects[MESH]|Humans[MESH]|Neoplasm Metastasis/*drug therapy[MESH]|Neoplasms/blood supply/*drug therapy/*pathology[MESH]|Protein-Tyrosine Kinases/antagonists & inhibitors[MESH]|Vascular Endothelial Growth Factor A/drug effects[MESH] |
